Skip to main content

Advertisement

Table 2 ORs for remission after 1 year of follow-up

From: Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis

Model Variable CD8+ T cells CD4+ T cells CD19+ B cells CD14+ monocytes
   OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Unadjusted pJAK1 0.57 (0.25–1.18) 0.14 0.47 (0.18–1.03) 0.053 0.75 (0.36–1.49) 0.42 0.78 (0.38–1.56) 0.49
  pJAK2 0.96 (0.48–1.89) 0.90 0.63 (0.30–1.26) 0.20 0.95 (0.48–1.88) 0.88 0.55 (0.25–1.10) 0.092
  pJAK3 3.01 (1.20–9.55) 0.017 2.40 (1.08–6.11) 0.032 2.19 (1.03–5.32) 0.044 1.84 (0.91–4.00) 0.094
  pTyk2 1.34 (0.64–3.24) 0.49 1.23 (0.61–2.84) 0.61 1.46 (0.65–3.78) 0.44 0.92 (0.46–1.82) 0.80
Adjusteda pJAK1 0.42 (0.13–1.14) 0.083 0.46 (0.16–1.09) 0.077 0.68 (0.30–1.49) 0.32 0.84 (0.36–1.94) 0.70
  pJAK2 0.97 (0.46–2.1) 0.94 0.53 (0.25–1.20) 0.14 0.66 (0.29–1.42) 0.29 0.42 (0.16–0.96) 0.034
  pJAK3 3.87 (1.33–16.65) 0.009 2.73 (1.16–7.90) 0.017 2.87 (1.11–8.87) 0.029 2.22 (1.01–5.31) 0.045
  pTyk2 1.40 (0.64–3.25) 0.45 1.32 (0.62–3.05) 0.52 1.47 (0.63–3.47) 0.44 0.92 (0.45–1.93) 0.83
  1. pJAK Phosphorylated Janus kinase, Tyk Tyrosine kinase
  2. a The models are adjusted for anti-citrullinated protein antibody, number of disease-modifying antirheumatic drugs at entry, smoking, and white blood cell count. ORs are calculated per 1 SD